Juan José Yepes-Núñez

Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐ <scp>EAACI</scp> Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

Intranasal Treatments for Allergic Rhinitis in Preschool- and School-Age Children: Network Meta-Analysis

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis

Patients' values and preferences for health states in allergic rhinitis—An artificial intelligence supported systematic review

Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis

Empirical estimation of disutilities and decision thresholds for composite endpoints

Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas

Biologicals in atopic disease in pregnancy: An EAACI position paper

DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics